CovidStanfordV1, Main, Exploration, bibRecord, 000849

A SARS-CoV-2 mRNA Vaccine - Preliminary Report.

Identifieur interne : 000849 ( Main/Exploration ); précédent : 000848; suivant : 000850

A SARS-CoV-2 mRNA Vaccine - Preliminary Report.

Auteurs : Ronald A. Schachar [Oman] ; Ira H. Schachar [États-Unis]

Source :

The New England journal of medicine [ 1533-4406 ] ; 2020.

RBID : pubmed:32813940

Descripteurs français

KwdFr :
- ARN messager (MeSH), Betacoronavirus (MeSH), Humains (MeSH), Infections à coronavirus (prévention et contrôle), Pandémies (MeSH), Pneumopathie virale (MeSH), Vaccins antiviraux (MeSH).
MESH :
- prévention et contrôle : Infections à coronavirus.
- ARN messager, Betacoronavirus, Humains, Pandémies, Pneumopathie virale, Vaccins antiviraux.

English descriptors

KwdEn :
- Betacoronavirus (MeSH), COVID-19 (MeSH), COVID-19 Vaccines (MeSH), Coronavirus Infections (prevention & control), Humans (MeSH), Pandemics (MeSH), Pneumonia, Viral (MeSH), RNA, Messenger (MeSH), SARS-CoV-2 (MeSH), Viral Vaccines (MeSH).
MESH :
- chemical : COVID-19 Vaccines, RNA, Messenger, Viral Vaccines.
- prevention & control : Coronavirus Infections.
- Betacoronavirus, COVID-19, Humans, Pandemics, Pneumonia, Viral, SARS-CoV-2.

DOI: 10.1056/NEJMc2026616
PubMed: 32813940

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000418
to stream Main, to step Curation: 000418

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A SARS-CoV-2 mRNA Vaccine - Preliminary Report.</title>
<author><name sortKey="Schachar, Ronald A" sort="Schachar, Ronald A" uniqKey="Schachar R" first="Ronald A" last="Schachar">Ronald A. Schachar</name>
<affiliation wicri:level="1"><nlm:affiliation>University of Texas at Arlington, Arlington, TX ron@2ras.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>University of Texas at Arlington, Arlington</wicri:regionArea>
<wicri:noRegion>Arlington</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schachar, Ira H" sort="Schachar, Ira H" uniqKey="Schachar I" first="Ira H" last="Schachar">Ira H. Schachar</name>
<affiliation wicri:level="2"><nlm:affiliation>Stanford University, Stanford, CA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Stanford University, Stanford</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32813940</idno>
<idno type="pmid">32813940</idno>
<idno type="doi">10.1056/NEJMc2026616</idno>
<idno type="wicri:Area/Main/Corpus">000418</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000418</idno>
<idno type="wicri:Area/Main/Curation">000418</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000418</idno>
<idno type="wicri:Area/Main/Exploration">000418</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">A SARS-CoV-2 mRNA Vaccine - Preliminary Report.</title>
<author><name sortKey="Schachar, Ronald A" sort="Schachar, Ronald A" uniqKey="Schachar R" first="Ronald A" last="Schachar">Ronald A. Schachar</name>
<affiliation wicri:level="1"><nlm:affiliation>University of Texas at Arlington, Arlington, TX ron@2ras.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>University of Texas at Arlington, Arlington</wicri:regionArea>
<wicri:noRegion>Arlington</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schachar, Ira H" sort="Schachar, Ira H" uniqKey="Schachar I" first="Ira H" last="Schachar">Ira H. Schachar</name>
<affiliation wicri:level="2"><nlm:affiliation>Stanford University, Stanford, CA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Stanford University, Stanford</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">The New England journal of medicine</title>
<idno type="eISSN">1533-4406</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>COVID-19 Vaccines (MeSH)</term>
<term>Coronavirus Infections (prevention & control)</term>
<term>Humans (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (MeSH)</term>
<term>RNA, Messenger (MeSH)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Viral Vaccines (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>ARN messager (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (prévention et contrôle)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (MeSH)</term>
<term>Vaccins antiviraux (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>COVID-19 Vaccines</term>
<term>RNA, Messenger</term>
<term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Infections à coronavirus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term>
<term>COVID-19</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Pneumonia, Viral</term>
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>ARN messager</term>
<term>Betacoronavirus</term>
<term>Humains</term>
<term>Pandémies</term>
<term>Pneumopathie virale</term>
<term>Vaccins antiviraux</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">32813940</PMID>
<DateCompleted><Year>2020</Year>
<Month>09</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1533-4406</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>383</Volume>
<Issue>12</Issue>
<PubDate><Year>2020</Year>
<Month>09</Month>
<Day>17</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N Engl J Med</ISOAbbreviation>
</Journal>
<ArticleTitle>A SARS-CoV-2 mRNA Vaccine - Preliminary Report.</ArticleTitle>
<Pagination><MedlinePgn>1190-1191</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1056/NEJMc2026616</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">10.1056/NEJMc2026616#sa1</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schachar</LastName>
<ForeName>Ronald A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo><Affiliation>University of Texas at Arlington, Arlington, TX ron@2ras.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Schachar</LastName>
<ForeName>Ira H</ForeName>
<Initials>IH</Initials>
<AffiliationInfo><Affiliation>Stanford University, Stanford, CA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
<PublicationType UI="D016420">Comment</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>08</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
<ISSNLinking>0028-4793</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>N Engl J Med. 2020 Jul 14;:</RefSource>
<PMID Version="1">32663912</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2020 Sep 17;383(12):1191-1192</RefSource>
<PMID Version="1">32813942</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014765" MajorTopicYN="Y">Viral Vaccines</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>8</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>9</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>8</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32813940</ArticleId>
<ArticleId IdType="doi">10.1056/NEJMc2026616</ArticleId>
<ArticleId IdType="pii">10.1056/NEJMc2026616#sa1</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Oman</li>
<li>États-Unis</li>
</country>
<region><li>Californie</li>
</region>
</list>
<tree><country name="Oman"><noRegion><name sortKey="Schachar, Ronald A" sort="Schachar, Ronald A" uniqKey="Schachar R" first="Ronald A" last="Schachar">Ronald A. Schachar</name>
</noRegion>
</country>
<country name="États-Unis"><region name="Californie"><name sortKey="Schachar, Ira H" sort="Schachar, Ira H" uniqKey="Schachar I" first="Ira H" last="Schachar">Ira H. Schachar</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidStanfordV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000849 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000849 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidStanfordV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32813940
   |texte=   A SARS-CoV-2 mRNA Vaccine - Preliminary Report.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32813940" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidStanfordV1

This area was generated with Dilib version V0.6.38.
Data generation: Tue Feb 2 21:24:25 2021. Site generation: Tue Feb 2 21:26:08 2021

	Serveur d'exploration sur le Covid à Stanford
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le Covid à Stanford

A SARS-CoV-2 mRNA Vaccine - Preliminary Report.

A SARS-CoV-2 mRNA Vaccine - Preliminary Report.

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki